Pipeline
Research goal
-
Novel vaccine adjuvants and delivery system Development of a vaccine adjuvant and POC with
candidate vaccine antigens- Improved efficacy profile for high-risk groups (elderly or immunocompromised group)
- Dose-sparing effects for healthy population
Development of novel delivery platforms and POC with candidate vaccine antigens
- Vectored or nucleic acid-based delivery as rapid
response to outbreak - Needle-free delivery of antigens for enhanced
efficacy and safety profile